EG18181A - Process for preparing hydroxy and alkoxy pyrimidine - Google Patents

Process for preparing hydroxy and alkoxy pyrimidine

Info

Publication number
EG18181A
EG18181A EG453/86A EG45386A EG18181A EG 18181 A EG18181 A EG 18181A EG 453/86 A EG453/86 A EG 453/86A EG 45386 A EG45386 A EG 45386A EG 18181 A EG18181 A EG 18181A
Authority
EG
Egypt
Prior art keywords
preparing hydroxy
alkoxy pyrimidine
pyrimidine
alkoxy
hydroxy
Prior art date
Application number
EG453/86A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of EG18181A publication Critical patent/EG18181A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
EG453/86A 1985-07-24 1986-07-22 Process for preparing hydroxy and alkoxy pyrimidine EG18181A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/758,199 US4711888A (en) 1985-07-24 1985-07-24 Hydroxy and alkoxy pyrimidines

Publications (1)

Publication Number Publication Date
EG18181A true EG18181A (en) 1992-09-30

Family

ID=25050889

Family Applications (1)

Application Number Title Priority Date Filing Date
EG453/86A EG18181A (en) 1985-07-24 1986-07-22 Process for preparing hydroxy and alkoxy pyrimidine

Country Status (25)

Country Link
US (1) US4711888A (xx)
EP (1) EP0210044B1 (xx)
JP (1) JPH0647579B2 (xx)
KR (1) KR890001549B1 (xx)
CN (1) CN1006792B (xx)
AU (1) AU569194B2 (xx)
CA (1) CA1265519A (xx)
DD (1) DD248588A5 (xx)
DE (1) DE3673718D1 (xx)
DK (1) DK162986C (xx)
EG (1) EG18181A (xx)
ES (1) ES2000734A6 (xx)
FI (1) FI89911C (xx)
GR (1) GR861917B (xx)
HU (1) HU196764B (xx)
IE (1) IE63404B1 (xx)
IL (1) IL79471A0 (xx)
NO (1) NO173442C (xx)
NZ (1) NZ216951A (xx)
PH (1) PH22484A (xx)
PL (2) PL150617B1 (xx)
PT (1) PT83036B (xx)
SU (1) SU1574171A3 (xx)
YU (1) YU45020B (xx)
ZA (1) ZA865489B (xx)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG47583A1 (en) * 1986-01-13 1998-04-17 American Cyanamid Co 4,5,6-Substituted-n- (substituted-phenyl) -2- pyrimidinamines
US4959365A (en) * 1986-10-31 1990-09-25 Pfizer Inc. Topical compositions of lipophilic pharmaceuticals agents
HU199683B (en) * 1987-07-22 1990-03-28 Egyt Gyogyszervegyeszeti Gyar Process for producing pharmaceutical compositions analgesic, antiphlogistic, antipyretic, antianginic and/or antioxidative activity
HU206203B (en) * 1987-12-02 1992-09-28 Pfizer Process for producing acyl derivatives of hydroxypyrimidines
US5071852A (en) * 1988-12-14 1991-12-10 Pfizer Inc. Derivatives of 5-hydroxy and 5-methoxy 2-amino-pyrimidines as inhibitors of interleukin-1 production
ATE96321T1 (de) * 1988-12-14 1993-11-15 Pfizer Derivate von 5-hydroxy- und 5-methoxy-2-aminopyrimidin als inhibitoren der interleukin-1produktion.
US4940712A (en) * 1989-05-26 1990-07-10 Pfizer Inc. Derivatives of hydroxyprimidines as leukotriene synthesis inhibitors
US5177079A (en) * 1991-01-31 1993-01-05 Warner-Lambert Company 2-substituted-4,6-di-tertiarybutyl-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents
CA2099868C (en) * 1991-01-31 2002-04-02 Thomas Richard Belliotti Substituted 4,6-di-tertiary-butyl-5-hydroxy-pyrimidines
US5248682A (en) * 1991-01-31 1993-09-28 Warner-Lambert Company 2-substituted-4,6-di-tertiary-butyl-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents
US5270319A (en) * 1991-09-09 1993-12-14 Warner-Lambert Company 5-hydroxy-2-pyrimidinylmethylene derivatives useful as antiinflammatory agents
US5196431A (en) * 1992-02-24 1993-03-23 Warner-Lambert Company 2-substituted amino-4, 6-di-tertiary-buthyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents
US5220025A (en) * 1992-02-24 1993-06-15 Warner-Lambert Company 2-substituted amino-4, 6-di-tertiary-butyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents
EP0902019A4 (en) * 1996-05-16 2002-03-27 Nissan Chemical Ind Ltd METHOD FOR PRODUCING PYRIMIDINE COMPOUNDS
US5958934A (en) * 1996-05-23 1999-09-28 Syntex (U.S.A.) Inc. Aryl pyrimidine derivatives and uses thereof
US5952331A (en) * 1996-05-23 1999-09-14 Syntex (Usa) Inc. Aryl pyrimidine derivatives
TW440563B (en) * 1996-05-23 2001-06-16 Hoffmann La Roche Aryl pyrimidine derivatives and a pharmaceutical composition thereof
US6489344B1 (en) 1998-06-19 2002-12-03 Chiron Corporation Inhibitors of glycogen synthase kinase 3
US7045519B2 (en) 1998-06-19 2006-05-16 Chiron Corporation Inhibitors of glycogen synthase kinase 3
WO2002000683A2 (en) * 2000-06-23 2002-01-03 Vanderbilt University Novel chain-breaking antioxidants
DE102004054080A1 (de) * 2004-11-09 2006-05-11 Wella Ag Haut- oder Haarbehandlungsmittel mit Schutzeffekt
US8367669B2 (en) * 2005-06-15 2013-02-05 Vanderbilt University Inhibitors of hemeprotein-catalyzed lipid peroxidation
US9133212B1 (en) 2005-06-15 2015-09-15 Vanderbilt University Inhibitors of hemeprotein-catalyzed lipid peroxidation
JP2008156048A (ja) * 2006-12-22 2008-07-10 Isamu Nakamura 車両用板材キャリア
US8877766B2 (en) 2013-02-15 2014-11-04 Peter F. Kador Neuroprotective multifunctional antioxidants and their monofunctional analogs

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN153791B (xx) 1979-03-10 1984-08-18 Soc D Etudes Prod Chimique
US4659363A (en) * 1983-07-25 1987-04-21 Ciba-Geigy Corporation N-(2-nitrophenyl)-2-aminopyrimidine derivatives, the preparation and use thereof
US4554276A (en) * 1983-10-03 1985-11-19 Pfizer Inc. 2-Amino-5-hydroxy-4-methylpyrimidine derivatives
EP0164204A1 (en) * 1984-05-12 1985-12-11 FISONS plc Novel pharmaceutically useful pyrimidines

Also Published As

Publication number Publication date
NO862956L (no) 1987-01-26
KR890001549B1 (ko) 1989-05-08
EP0210044B1 (en) 1990-08-29
DK349486D0 (da) 1986-07-23
HU196764B (en) 1989-01-30
DK349486A (da) 1987-01-25
CN1006792B (zh) 1990-02-14
ES2000734A6 (es) 1988-03-16
PH22484A (en) 1988-09-12
PT83036A (en) 1986-08-01
NO173442C (no) 1993-12-15
EP0210044A2 (en) 1987-01-28
FI863029A0 (fi) 1986-07-23
PL151571B1 (en) 1990-09-28
PL271856A1 (en) 1988-09-29
PL150617B1 (en) 1990-06-30
CA1265519A (en) 1990-02-06
JPS6226276A (ja) 1987-02-04
AU569194B2 (en) 1988-01-21
DE3673718D1 (de) 1990-10-04
ZA865489B (en) 1988-03-30
FI89911B (fi) 1993-08-31
YU45020B (en) 1991-06-30
US4711888A (en) 1987-12-08
JPH0647579B2 (ja) 1994-06-22
HUT41745A (en) 1987-05-28
CN86104539A (zh) 1987-01-21
SU1574171A3 (ru) 1990-06-23
YU132186A (en) 1988-04-30
IL79471A0 (en) 1986-10-31
FI89911C (fi) 1993-12-10
FI863029A (fi) 1987-01-25
DK162986B (da) 1992-01-06
PT83036B (pt) 1989-01-30
DK162986C (da) 1992-06-01
AU6044786A (en) 1987-04-30
DD248588A5 (de) 1987-08-12
PL260784A1 (en) 1988-08-18
GR861917B (en) 1986-11-24
EP0210044A3 (en) 1987-10-21
NZ216951A (en) 1989-06-28
NO173442B (no) 1993-09-06
IE63404B1 (en) 1995-04-19
IE861952L (en) 1987-01-24
NO862956D0 (no) 1986-07-23
KR870001173A (ko) 1987-03-11

Similar Documents

Publication Publication Date Title
EG18181A (en) Process for preparing hydroxy and alkoxy pyrimidine
PT82226A (en) Process for the preparation of 3-aryluraciles and pesticeides therewith
PT81835B (en) Process for the preparation of spirodioxolanes spirodithiolanes and spirooxothiolanes
GB2184441B (en) Pyrimidine derivatives
GB2178424B (en) Process and intermediates for preparing 1a-hydroxyvitamin d compounds
EP0263309A3 (en) Bromofluoroethylhypofluorite and process for its preparation
ZA861619B (en) Glycoside and process for preparation thereof
PH25080A (en) Novel pesticidal-1-(alkyl-phenoxyaryl)-3-benzoyl ureas and process for preparation
DE3660220D1 (en) Process for the preparation of chloronitroanilines and chloronitrophenols
EP0214651A3 (en) Method for preparing 3-ethylbenzophenone
DE3664473D1 (en) Epoxysteroid ucy1003 and process for preparing the same
DE3662097D1 (en) 4-mercaptobenzonitriles and process for their preparation
DE3665866D1 (en) Method for silalactone preparation and use
PL249198A1 (en) Process for preparing n-phosphonmethylglycine and its derivatives
EP0191401A3 (en) Novel antiallergic agents and process for their preparation
ZA86911B (en) Modified enzyme and process for its preparation
EP0215439A3 (en) Method for preparing 3-ethylbenzophenone
DE3661635D1 (en) Ketosultams and process for their preparation
HUT40657A (en) Process for preparing imidazo-isoquinoline and imidazo-thieno-pyridine derivatives
PT83219A (en) Process for preparing novel pyrimidine derivatives
BG41375A1 (en) N- benzyloxycarbonyl- l- thyrozyl- glycyl- l- leucine and method for its preparing
GR862408B (en) Method for preparing alkenylazoles and their application
GR862007B (en) Method for preparing cyclo-alifatic cetoamines
GB8523485D0 (en) Brewing process
BG39545A1 (en) Method for preparing rifamizine s